Details of the Drug
General Information of Drug (ID: DMUILX8)
Drug Name |
N-(2-phenylimidazo[1,2-a]pyridin-3-yl)benzamide
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
N-(2-phenylimidazo[1,2-a]pyridin-3-yl)benzamide; CHEMBL379553; 171628-57-2; N-{2-phenylimidazo[1,2-a]pyridin-3-yl}benzamide; AC1LF77Z; Oprea1_830806; MLS001162915; CTK0E4651; DTXSID60353680; MolPort-002-132-975; HMS2842E11; ZINC193750; BDBM50187634; STK367224; AKOS001415177; MCULE-3771425109; SMR000495823; SR-01000196826; N-(2-Phenylimidazo[1,2-a]pyridine-3-yl)benzamide; SR-01000196826-1; Benzamide, N-(2-phenylimidazo[1,2-a]pyridin-3-yl)-
|
||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
Small molecular drug
|
||||||||||||||||||||||
Structure | |||||||||||||||||||||||
3D MOL | 2D MOL | ||||||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 313.4 | |||||||||||||||||||||
Logarithm of the Partition Coefficient (xlogp) | 4.6 | ||||||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | ||||||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 1 | ||||||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 2 | ||||||||||||||||||||||
Chemical Identifiers |
|
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||